turned another block of text into a bulleted list. Still not sure on this content itself (feels like a copy-and-paste job from somewhere) but it's at least cleaner.
| ← Previous revision |
Revision as of 14:12, 22 April 2026 |
| Line 49: |
Line 49: |
|
"Vertical integration" has met with considerable pushback and claims of antitrust law violations. The Federal Trade Commission (FTC) has accused major pharmacy benefit managers (PBMs), including CVS Caremark and OptumRx, of engaging in anticompetitive practices that harm competition and raise drug prices, citing conflicts of interest and exclusivity provisions.[{{Cite news |date=July 9, 2024 |title=Middlemen Have Outsized Influence on US Drug Prices Due to Market Consolidation, FTC Says |url=https://www.reuters.com/business/healthcare-pharmaceuticals/middlemen-have-outsized-influence-us-drug-prices-due-market-consolidation-ftc-2024-07-09/ |access-date=December 5, 2024 |work=Reuters}}][{{Cite news |date=July 10, 2024 |title=Feds Poised to Sue Pharmacy Gatekeepers over High Insulin Prices as Part of Broader Probe into Drug Costs |url=https://www.politico.com/news/2024/07/10/ftc-pharmacy-insulin-drug-00167342/ |access-date=December 5, 2024 |work=Politico}}] Similarly, the American Medical Association (AMA) has criticized the CVS-Aetna merger, arguing it undermines competition in pharmacy benefit management services, health insurance, and retail pharmacy markets, leading to higher consumer costs and fewer choices.[{{Cite web |date=2018 |title=CVS-Aetna Merger Would Reduce Competition, AMA Says |url=https://www.ama-assn.org/health-care-advocacy/access-care/cvs-aetna-merger |access-date=December 5, 2024 |website=American Medical Association |archive-date=December 13, 2024 |archive-url=https://web.archive.org/web/20241213201429/https://www.ama-assn.org/health-care-advocacy/access-care/cvs-aetna-merger |url-status=live }}] |
|
"Vertical integration" has met with considerable pushback and claims of antitrust law violations. The Federal Trade Commission (FTC) has accused major pharmacy benefit managers (PBMs), including CVS Caremark and OptumRx, of engaging in anticompetitive practices that harm competition and raise drug prices, citing conflicts of interest and exclusivity provisions.[{{Cite news |date=July 9, 2024 |title=Middlemen Have Outsized Influence on US Drug Prices Due to Market Consolidation, FTC Says |url=https://www.reuters.com/business/healthcare-pharmaceuticals/middlemen-have-outsized-influence-us-drug-prices-due-market-consolidation-ftc-2024-07-09/ |access-date=December 5, 2024 |work=Reuters}}][{{Cite news |date=July 10, 2024 |title=Feds Poised to Sue Pharmacy Gatekeepers over High Insulin Prices as Part of Broader Probe into Drug Costs |url=https://www.politico.com/news/2024/07/10/ftc-pharmacy-insulin-drug-00167342/ |access-date=December 5, 2024 |work=Politico}}] Similarly, the American Medical Association (AMA) has criticized the CVS-Aetna merger, arguing it undermines competition in pharmacy benefit management services, health insurance, and retail pharmacy markets, leading to higher consumer costs and fewer choices.[{{Cite web |date=2018 |title=CVS-Aetna Merger Would Reduce Competition, AMA Says |url=https://www.ama-assn.org/health-care-advocacy/access-care/cvs-aetna-merger |access-date=December 5, 2024 |website=American Medical Association |archive-date=December 13, 2024 |archive-url=https://web.archive.org/web/20241213201429/https://www.ama-assn.org/health-care-advocacy/access-care/cvs-aetna-merger |url-status=live }}] |
|
|
|
|
|
=== Leadership === |
|
=== Leadership timeline === |
|
|
|
| ⚫ |
July 2011: Larry Renfro is named as Optum CEO. [{{Cite press release |title=]Larry Renfro Named CEO of Optum |date=July 6, 2011 |publisher=UnitedHealth Group |location=Minnetonka, Minnesota |url=https://www.businesswire.com/news/home/20110706005573/en/Larry-Renfro-Named-CEO-of-Optum |archive-url=https://web.archive.org/web/20240119165504/https://www.businesswire.com/news/home/20110706005573/en/Larry-Renfro-Named-CEO-of-Optum |archive-date=January 19, 2024 |agency=BusinessWire.com}} |
|
|
March 2018: Optum announces Larry Renfro to step down as Optum CEO. name="PR 2018-03-13">{{Cite press release |title=UnitedHealth Group Announces Leadership Actions |date=March 13, 2018 |publisher=UnitedHealth Group |location=Minneapolis |url=https://www.businesswire.com/news/home/20180313005535/en/UnitedHealth-Group-Announces-Leadership-Actions |archive-url=https://web.archive.org/web/20240119165502/https://www.businesswire.com/news/home/20180313005535/en/UnitedHealth-Group-Announces-Leadership-Actions |archive-date=January 19, 2024 |agency=BusinessWire.com}}
|
|
* July 2011: Larry Renfro is named as Optum CEO.[{{Cite press release |title=Larry Renfro Named CEO of Optum |date=July 6, 2011 |publisher=UnitedHealth Group |location=Minnetonka, Minnesota |url=https://www.businesswire.com/news/home/20110706005573/en/Larry-Renfro-Named-CEO-of-Optum |archive-url=https://web.archive.org/web/20240119165504/https://www.businesswire.com/news/home/20110706005573/en/Larry-Renfro-Named-CEO-of-Optum |archive-date=January 19, 2024 |agency=BusinessWire.com}}] |
|
⚫ |
* March 2018: Optum announces Larry Renfro to step down as Optum CEO. name="PR 2018-03-13">{{Cite press release |title=UnitedHealth Group Announces Leadership Actions |date=March 13, 2018 |publisher=UnitedHealth Group |location=Minneapolis |url=https://www.businesswire.com/news/home/20180313005535/en/UnitedHealth-Group-Announces-Leadership-Actions |archive-url=https://web.archive.org/web/20240119165502/https://www.businesswire.com/news/home/20180313005535/en/UnitedHealth-Group-Announces-Leadership-Actions |archive-date=January 19, 2024 |agency=BusinessWire.com}} |
|
July 2018: [[Andrew Witty|Sir Andrew Witty]] starts as CEO of Optum. |
|
* July 2018: [[Andrew Witty|Sir Andrew Witty]] starts as CEO of Optum. |
|
February 2021: Andrew Witty appointed as CEO of [[UnitedHealth Group]] (Optum's parent company). No successor to the Optum CEO role is named.[{{Cite press release |title=UnitedHealth Group Announces Executive Leadership Actions |date=February 4, 2021 |publisher=UnitedHealth Group |location=Minnetonka, Minnesota |url=https://www.businesswire.com/news/home/20210204005587/en/UnitedHealth-Group-Announces-Executive-Leadership-Actions |access-date=May 27, 2025 |agency=BusinessWire.com |archive-date=January 14, 2025 |archive-url=https://web.archive.org/web/20250114050527/https://www.businesswire.com/news/home/20210204005587/en/UnitedHealth-Group-Announces-Executive-Leadership-Actions |url-status=live }}] |
|
* February 2021: Andrew Witty appointed as CEO of [[UnitedHealth Group]] (Optum's parent company). No successor to the Optum CEO role is named.[{{Cite press release |title=UnitedHealth Group Announces Executive Leadership Actions |date=February 4, 2021 |publisher=UnitedHealth Group |location=Minnetonka, Minnesota |url=https://www.businesswire.com/news/home/20210204005587/en/UnitedHealth-Group-Announces-Executive-Leadership-Actions |access-date=May 27, 2025 |agency=BusinessWire.com |archive-date=January 14, 2025 |archive-url=https://web.archive.org/web/20250114050527/https://www.businesswire.com/news/home/20210204005587/en/UnitedHealth-Group-Announces-Executive-Leadership-Actions |url-status=live }}] |
|
April 2024: Heather Cianfrocco is named CEO of Optum.[{{Cite web |title=UnitedHealth Group Executive Management Team |url=https://www.unitedhealthgroup.com/people-and-businesses/our-leaders/heather-cianfrocco.html |access-date=July 3, 2024 |publisher=*[[UnitedHealth Group]]}}] |
|
|
April 2025: Patrick Conway is named CEO of Optum, replacing Heather Cianfrocco who has moved to a new role as executive vice president of governance, compliance, and information security at Optum.[{{cite news |date=April 2025 |title=UnitedHealth names insider Patrick Conway as Optum CEO |url=https://www.reuters.com/business/healthcare-pharmaceuticals/unitedhealth-names-patrick-conway-lead-healthcare-services-business-2025-04-29/ |access-date=July 2, 2025 |archive-date=April 30, 2025 |archive-url=https://web.archive.org/web/20250430081946/https://www.reuters.com/business/healthcare-pharmaceuticals/unitedhealth-names-patrick-conway-lead-healthcare-services-business-2025-04-29/ |url-status=live }}] |
|
* April 2024: Heather Cianfrocco is named CEO of Optum.[{{Cite web |title=UnitedHealth Group Executive Management Team |url=https://www.unitedhealthgroup.com/people-and-businesses/our-leaders/heather-cianfrocco.html |access-date=July 3, 2024 |publisher=*[[UnitedHealth Group]]}}] |
|
|
* April 2025: Patrick Conway is named CEO of Optum, replacing Heather Cianfrocco who has moved to a new role as executive vice president of governance, compliance, and information security at Optum.[{{cite news |date=April 2025 |title=UnitedHealth names insider Patrick Conway as Optum CEO |url=https://www.reuters.com/business/healthcare-pharmaceuticals/unitedhealth-names-patrick-conway-lead-healthcare-services-business-2025-04-29/ |access-date=July 2, 2025 |archive-date=April 30, 2025 |archive-url=https://web.archive.org/web/20250430081946/https://www.reuters.com/business/healthcare-pharmaceuticals/unitedhealth-names-patrick-conway-lead-healthcare-services-business-2025-04-29/ |url-status=live }}] |
|
|
|
|
== Controversies == |
|
== Controversies == |
|
=== Haven lawsuit === |
|
=== Haven lawsuit === |
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
